TransCode Therapeutics Inc (NASDAQ:RNAZ) currently has a daily average trading volume of 6.60M but it saw 3397539 shares traded in last market. With a market cap of 0.36M USD, the company’s current market price of $0.52 came falling about -11.86 while comparing to the previous closing price of $0.59. In past 52 weeks, the stock remained buoying in the range of price level as high as $66.33 and as low as $0.58. In the recent trading on the day, stock has struck highest price mark of $0.5162 while lowest mark touched by it was $0.5785.
Taking a look at 20-day trading activity of TransCode Therapeutics Inc (RNAZ) gives us an average price of $1.1315, while its current price level is -99.22% below from 52-week high level whereas it is -10.42% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $4.9211 while that of 200 days or SMA-200 reads an average of $12.7679. A closer look into the stock’s movement over the week reveals that its volatility is standing at 30.01% during that period while stretching the period over a month that decreases to 22.34%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 27.84 which implies that the stock is in oversold territory.
Over the week, RNAZ’s stock price is moving -32.47% down while it is -84.48% when we observe its performance for the past one month. Year-to-date it is -84.57% down and over the past year, the stock is showing a downside performance of -97.68%.
Currently, TransCode Therapeutics Inc’s total number of outstanding shares is 0.70M. Company’s return on investment (ROI) stands at -903.45% and return on equity (ROE) at -490.03%. Stock’s beta reads 1.42. Stock has a price to book (P/B) ratio of 0.16. Its return on asset (ROA) is -210.77% on average.
